Recipient of federal assistance · DURHAM, NC

AIMMAX THERAPEUTICS INC

AIMMAX THERAPEUTICS INC received -$7,716 in federal grants and other assistance in FY2026, on 4 actions, −101% vs FY2025. It has no federal contracts in the loaded years. Since FY2022: $4.9M.

Assistance · FY2026
-$7,716
New awards
0
Actions
4
Since FY2022
$4.9M
UEI
VCBNGNMH78J9
Location
DURHAM, NC
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 613.4KFY2022
  2. 1.6MFY2023
  3. 1.6MFY2024
  4. 1MFY2025
  5. -7.7KFY2026

By type

  1. Grants-$7,7160.0%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.855 · Allergy and Infectious Diseases Research-$7,7160.0%

Largest awards

  1. DEVELOPMENT OF A NOVEL ORAL ANTIBIOTIC FOR THE TREATMENT OF DRUG RESISTANT GONORRHEA - PROJECT SUMMARY / ABSTRACT THE CDC HAS IDENTIFIED…$3.4M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Aug 8, 2022 – Jul 16, 2026· R44AI170150
  2. DEVELOPMENT OF A NOVEL INJECTABLE ANTIBIOTIC TO TREAT SERIOUS MULTIDRUG-RESISTANT GRAM-POSITIVE INFECTIONS - PROJECT SUMMARY / ABSTRACT…$613.9K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· May 4, 2023 – Mar 11, 2026· R43AI174384
  3. OPTIMIZATION AND CHARACTERIZATION OF NOVEL ANTIFUNGAL PEPTIDES - PROJECT SUMMARY / ABSTRACT INVASIVE CANDIDIASIS IS A DISEASE ASSOCIATED…$605.2K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· May 10, 2022 – Jul 21, 2026· R43AI164986

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2022–FY2026.